Mechanisms of protection against rotavirus infection and disease

Pediatric Infectious Disease Journal

Volumn 28, Issue SUPPL. 3, 2009, Pages

  Ward, Richard ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Antibody; Gastroenteritis; Protection; Reoviridae; Rotavirus; Rotavirus vaccine

Indexed keywords

ENTEROTOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; PLACEBO; ROTAVIRUS NONSTRUCTURAL PROTEIN 4; ROTAVIRUS VACCINE; VIRUS PROTEIN; VIRUS RNA; VIRUS ANTIBODY;

ANTIBODY RESPONSE; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMORAL IMMUNITY; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA VIRUS; ROTAVIRUS; TREATMENT OUTCOME; VACCINATION; VIRAL GASTROENTERITIS; VIRUS GENOME; VIRUS INFECTION; ANIMAL; BLOOD; IMMUNOLOGY; SERODIAGNOSIS; T LYMPHOCYTE; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, VIRAL; HUMANS; NEUTRALIZATION TESTS; ROTAVIRUS; ROTAVIRUS INFECTIONS; T-LYMPHOCYTES;

EID: 63849116536     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181967c16     Document Type: Article

References (22)

1. Cheever FS, Mueller JH. Epidemic diarrheal disease of suckling mice. I. Manifestations, epidemiology, and attempts to transmit the disease. J Exp Med. 1947;85:405- 416.
2. Pappenheimer AM, Enders JF. An epidemic diarrheal disease of suckling mice: II. Inclusions in the intestinal epithelial cell. J Exp Med. 1947;85: 417-422.
3. Malherbe H, Harwin R. The cytopathic effects of vervet monkey viruses. S Afr Med J. 1963;20:37:407- 411.
4. Adams WR, Kraft LM. Epizootic diarrhea of infant mice: identification of the etiologic agent. Science. 1963;26:141.
5. Bishop RF, Davidson GP, Holmes IH, et al. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet. 1973;2:1281-1283.
6. Bernstein DI, Ward RL. Rotaviruses. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Vol. 2. Philadelphia, PA: Saunders; 2004:2110 -2133.
7. Estes MK, Kapikian AZ. Rotaviruses. In: Knipe DM, Howley PM, Griffin DE, et al, eds. Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:1917-1974.
8. Ward RL. Rotavirus vaccines: how they work or don't work. Expert Rev Mol Med. 2008;10:1-14.
9. Dennehy PH. Rotavirus vaccines: an overview. Clin Microbiol Rev. 2008; 21:198 -208.
10. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007; 370:1757-1763.
11. McNeal MM, Barone KS, Rae MN, et al. Effector functions of antibody and CD8- cells in resolution of rotavirus infection and protection against reinfection in mice. Virology. 1995;214:387-397.
12. Franco MA, Tin C, Greenberg HB. CD8- T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice. J Virol. 1997;71:4165- 4170.
13. O'Ryan ML, Matson DO, Estes MK, et al. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J Infect Dis. 1994;169:504 -511.
14. Clemens JD, Ward RL, Rao MR, et al. Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J Infect Dis. 1992;165:161-165.
15. Vela'zquez FR, Matson DO, Guerrero ML, et al. Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis. 2000;182:1602-1609.
16. Matson DO, O'Ryan ML, Herrera I, et al. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J Infect Dis. 1993;167: 577-583.
17. Chiba S, Yokoyama T, Nakata S, et al. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet. 1986;2: 417-421.
18. Ward RL, Clemens JD, Knowlton DR, et al. Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J Infect Dis. 1992;166:1251-1257.
19. Ward RL, Bernstein DI; US Rotavirus Vaccine Efficacy Group. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. Vaccine. 1995;13:1226- 1232.
20. Ward RL, Knowlton DR, Zito ET, et al; US Rotavirus Vaccine Efficacy Group. Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. J Infect Dis. 1997;176:570 -577.
21. Vesikari T, Clark HF, Offit PA, et al. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine. 2006; 24:4821- 4829.
22. De Vos B, Vesikari T, Linhares AC, et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J. 2004;23(Suppl 10):S179 -S182.